-
1
-
-
0003415539
-
-
Chapman & Hall. / CRC, Boca Raton, London, New York, Washington, D.C.
-
Altman D.G. 1991 Practical Statistics for Medical Research 1st edn Chapman & Hall / CRC, Boca Raton, London, New York, Washington, D.C.
-
(1991)
Practical Statistics for Medical Research 1st Edn.
-
-
Altman, D.G.1
-
2
-
-
0021341367
-
Removal of HLA-A,B antigens from platelets
-
Blumberg N. Masel D. Mayer T. Horan P. Heal J. 1984 Removal of HLA-A,B antigens from platelets. Blood, 63, 448 450.
-
(1984)
Blood
, vol.63
, pp. 448-450
-
-
Blumberg, N.1
Masel, D.2
Mayer, T.3
Horan, P.4
Heal, J.5
-
3
-
-
0034658055
-
Thrombocyte HLA molecules retain nonrenewable endogenous peptides of megakaryocyte lineage and do not stimulate direct allocytotoxicity in vitro
-
Gouttefangeas C. Diehl M. Keilholz W. Hornlein R.F. Stevanovic S. Rammensee H.G. 2000 Thrombocyte HLA molecules retain nonrenewable endogenous peptides of megakaryocyte lineage and do not stimulate direct allocytotoxicity in vitro. Blood, 95, 3168 3175.
-
(2000)
Blood
, vol.95
, pp. 3168-3175
-
-
Gouttefangeas, C.1
Diehl, M.2
Keilholz, W.3
Hornlein, R.F.4
Stevanovic, S.5
Rammensee, H.G.6
-
4
-
-
0023214605
-
An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients
-
Heal J.M. Blumberg N. Masel D. 1987 An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients. Blood, 70, 23 30.
-
(1987)
Blood
, vol.70
, pp. 23-30
-
-
Heal, J.M.1
Blumberg, N.2
Masel, D.3
-
5
-
-
0022471868
-
Quantitative analysis of platelet surface HLA by W6/32 anti-HLA monoclonal antibody
-
Kao K.J. Cook D.J. Scornik J.C. 1986 Quantitative analysis of platelet surface HLA by W6/32 anti-HLA monoclonal antibody. Blood, 68, 627 632.
-
(1986)
Blood
, vol.68
, pp. 627-632
-
-
Kao, K.J.1
Cook, D.J.2
Scornik, J.C.3
-
6
-
-
0023864434
-
Association between HLA phenotype and HLA concentration in plasma or platelets
-
Kao K.J. Scornik J.C. Riley W.J. McQueen C.F. 1988 Association between HLA phenotype and HLA concentration in plasma or platelets. Human Immunology, 21, 115 124.
-
(1988)
Human Immunology
, vol.21
, pp. 115-124
-
-
Kao, K.J.1
Scornik, J.C.2
Riley, W.J.3
McQueen, C.F.4
-
8
-
-
0025667439
-
Separation of platelet concentrates (PC) from buffy coat (BC) using the bottom and top drainage (BAT) system
-
Kretschmer V. Biermann E. Loh H. 1990 Separation of platelet concentrates (PC) from buffy coat (BC) using the bottom and top drainage (BAT) system. Beitrage zur Infusionstherapie, 26, 65 70.
-
(1990)
Beitrage Zur Infusionstherapie
, vol.26
, pp. 65-70
-
-
Kretschmer, V.1
Biermann, E.2
Loh, H.3
-
10
-
-
0024419719
-
New approach to eliminate HLA class I antigens from platelet surface without cell damage: Acid treatment at pH 3.0
-
Kurata Y. Oshida M. Take H. Furubayashi T. Nakao H. Tomiyama Y. Kanayama Y. Nagao N. Okubo Y. Yonezawa T. 1989 New approach to eliminate HLA class I antigens from platelet surface without cell damage: acid treatment at pH 3.0. Vox Sanguinis, 57, 199 204.
-
(1989)
Vox Sanguinis
, vol.57
, pp. 199-204
-
-
Kurata, Y.1
Oshida, M.2
Take, H.3
Furubayashi, T.4
Nakao, H.5
Tomiyama, Y.6
Kanayama, Y.7
Nagao, N.8
Okubo, Y.9
Yonezawa, T.10
-
11
-
-
0020054538
-
Ability of thrombocytes to acquire HLA specificity from plasma
-
Lalezari P. Driscoll A.M. 1982 Ability of thrombocytes to acquire HLA specificity from plasma. Blood, 59, 167 170.
-
(1982)
Blood
, vol.59
, pp. 167-170
-
-
Lalezari, P.1
Driscoll, A.M.2
-
12
-
-
0027442598
-
Influence of chloroquine or acid treatment of human platelets on the antigenicity of HLA and the 'thrombocyte-specific' glycoproteins Ia/ IIa, IIb, and IIb/IIIa
-
Neumueller J. Tohidast-Akrad M. Fischer M. Mayr W.R. 1993 Influence of chloroquine or acid treatment of human platelets on the antigenicity of HLA and the 'thrombocyte-specific' glycoproteins Ia/ IIa, IIb, and IIb/IIIa. Vox Sanguinis, 65, 223 231.
-
(1993)
Vox Sanguinis
, vol.65
, pp. 223-231
-
-
Neumueller, J.1
Tohidast-Akrad, M.2
Fischer, M.3
Mayr, W.R.4
-
13
-
-
0029804655
-
The kinetics of HLA class I elution and the relevance for the use of HLA-eluted platelet transfusions
-
Novotny V.M. Doxiadis I.N. van Doorn R. Brand A. 1996a The kinetics of HLA class I elution and the relevance for the use of HLA-eluted platelet transfusions. British Journal of Haematology, 95, 416 422.
-
(1996)
British Journal of Haematology
, vol.95
, pp. 416-422
-
-
Novotny, V.M.1
Doxiadis, I.N.2
Van Doorn, R.3
Brand, A.4
-
15
-
-
0027301325
-
The presence of messenger RNA for HLA class I in human platelets and its capability for protein biosynthesis
-
Santoso S. Kiefel V. Mueller-Eckhardt C. 1993 The presence of messenger RNA for HLA class I in human platelets and its capability for protein biosynthesis. British Journal of Haematology, 84, 451 456.
-
(1993)
British Journal of Haematology
, vol.84
, pp. 451-456
-
-
Santoso, S.1
Kiefel, V.2
Mueller-Eckhardt, C.3
-
17
-
-
0017817650
-
Microdroplet testing for HLA-A-B-C, and - D antigens. the Phillip Levine Award Lecture
-
Terasaki P.I. Bernoco D. Park M.S. Ozturk G. Iwaki Y. 1978 Microdroplet testing for HLA-A-B-C, and - D antigens. The Phillip Levine Award Lecture. American Journal of Clinical Pathology, 69, 103 120.
-
(1978)
American Journal of Clinical Pathology
, vol.69
, pp. 103-120
-
-
Terasaki, P.I.1
Bernoco, D.2
Park, M.S.3
Ozturk, G.4
Iwaki, Y.5
-
18
-
-
37049049011
-
Microdroplet assay of human serum cytotoxins
-
Terasaki P.I. McClelland J.D. 1964 Microdroplet assay of human serum cytotoxins. Nature, 204, 998 1000.
-
(1964)
Nature
, vol.204
, pp. 998-1000
-
-
Terasaki, P.I.1
McClelland, J.D.2
-
19
-
-
2642611953
-
Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions
-
The Trial to Reduce Alloimmunization to Platelets Study Group
-
The Trial to Reduce Alloimmunization to Platelets Study Group 1997 Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. New England Journal of Medicine, 337, 1861 1869.
-
(1997)
New England Journal of Medicine
, vol.337
, pp. 1861-1869
-
-
-
20
-
-
0000213899
-
Richtlinien zur Gewinnug von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie)
-
Wissenschaftlicher Beirat der Bundesärztekammer
-
Wissenschaftlicher Beirat der Bundesärztekammer 2000 Richtlinien zur Gewinnug von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie). Bundesgesundheitsblatt, 43, 555 589.
-
(2000)
Bundesgesundheitsblatt
, vol.43
, pp. 555-589
-
-
|